Loading
Latest filing published 27 Sept 2021 for Rennova Health, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Christopher Eric Diamantis across 2 companies, led by Rennova Health, Inc. and Medytox Solutions, Inc. Between 5 May 2015 and 27 August 2021, the trades on record add up to 9 filings.
No open-market sale appears; the market trades are 4 purchases worth €2.6M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 2 share grants.
In size, the median ticket on the buying side is €200k.
Most recently, on 27 September 2021, the filings show a transaction in Rennova Health, Inc. The most recent open-market purchase was published on 19 July 2016, 3,749 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 27 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration